RE: Not Looking Good For AstraZeneca25 Nov 2020 12:00
ToffAppleton1/scriven - I'm in AZN and GSK so have an interest in both doing well. I don't mind which vaccine is the best from Pfizer, Moderna, Johnson and Johnson, GSK, AZN/Oxford or any other so long as they work and are approved.
GSK are big into vaccines while AZN never have been. Oncology is where AZN are at their best and if you did some research you would find that out. You could start with Tagrisso and NSCL and there are many more. Yes, my views are biased as I worked at AZN in oncology discovery chemistry for many years.
To suggest that AZN is over valued and is about to plunge is not clever.
As for mistakes yes it was an error giving half a dose in the trial but some would argue this was serendipity. The fact remains by accident they found a better dose regimen. They could have binned it but no, good scientific thinking reacted to the situation successfully. All these companies/organisations employ high class scientists who are experts in their fields and are extremely dedicated to what they do.
So easy to post on a share board shooting down one company or another because we think we know better.